BioAdaptives retires largest convertible debt, removing equity overhang - BDPT News | RalliesBioAdaptives retires largest convertible debt, removing equity overhang
B
BDPT• Convertible debt retired and dilution pressure reduced
- BioAdaptives retired its largest convertible commercial investor, clearing outstanding convertible debt and removing related equity overhang.
- The move eliminates near-term dilution risk from conversions, easing selling pressure tied to the convertible instrument.
- The company framed the transaction as a shift toward non-dilutive funding ahead of the XcellaraHeart launch in August.
CFR
•
